CHANGES IN THE ORAL CAVITY AFTER ANTIMYCOBACTERIAL DRUGS IN PATIENTS WITH PULMONARY TUBERCULOSIS

Abstract

his study investigates the impact of antimycobacterial drugs on oral cavity changes in patients diagnosed with pulmonary tuberculosis. Pulmonary tuberculosis, a global health concern, necessitates prolonged treatment with antimycobacterial drugs. While the primary focus is often on the pulmonary effects of these medications, their potential influence on oral health has been a subject of growing interest. The research employs a comprehensive approach, combining clinical observation and patient-reported outcomes to elucidate alterations in the oral cavity induced by antimycobacterial therapy.